Completed
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
NCT05286762
- Conditions
- ADHD, ADHD - Combined Type, Attention Deficit Disorder with Hyperactivity, +7 more
- Locations
-
- Clinical Neuroscience Solutions, Inc. Jacksonville, Florida, United States
- Meridien Research Maitland, Florida, United States
- Clinical Neuroscience Solutions, Inc. Orlando, Florida, United States
- Atlanta Center for Medical Research Atlanta, Georgia, United States